Average trial in this space takes 15 years to complete.
No, the average development cycle is 15 years. That includes pre-clinical, P1-P3. and approval.
DCVax has been in development for 30 years. 21 years NWBO had multiple P3/P2 trials ready to launch. But before that Boynton had been running early trials.